MedTrace Logo

Safety and Effectiveness of the AcuFocus Corneal Inlay ACI7000PDT in Presbyopes

NCT01352442 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 151

Last updated 2017-03-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if the AcuFocus Corneal Inlay ACI 7000PDT will provide an effective method of for the correction of presbyopia in patients who have normal distance vision but need correction such as glasses or contact lenses to see clearly at near.

Conditions

Interventions

DEVICE

AcuFocus Corneal Inlay ACI 7000PDT

corneal inlay

Sponsors & Collaborators

  • AcuFocus, Inc.

    lead INDUSTRY

Principal Investigators

  • Perry Binder, MD

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Australia
  • Austria
  • France
  • Japan
  • Netherlands
  • New Zealand
  • Philippines
  • Singapore
  • Spain
  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01352442 on ClinicalTrials.gov